BackBiodesix Overview

Biodesix Receivables

Latest receivables for BDSX: $9.5M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.50M
↑ 24.36% YoYΔ $1.86M vs prior year quarter

Peer average

Loading

Biodesix Receivables History

Loading

Biodesix vs. peers: Receivables Comparison

Loading

Biodesix Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biodesix (BDSX) FAQ

Biodesix (BDSX) currently reports a receivables of $9.5M as of March 2026. That compares with $7.6M in the prior-year period — up 24.4% year over year. Use the charts on this page to explore Biodesix's receivables history and peer comparisons.

Biodesix's receivables increased from $7.6M to $9.5M — a 24.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodesix reported $9.5M in receivables as of March 2026. That compares with $7.6M in the prior-year period — up 24.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $9.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biodesix, and consider following BDSX for alerts when major investors trade the stock.

Biodesix is classified in the Healthcare sector. On receivables, it currently shows $9.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDSX with unrelated industries.